A Web-Based Platform to Collect Data from ESRD Patients Undergoing Dialysis: Methods and Preliminary Results from the Brazilian Dialysis Registry
Table 4
Primary renal disease, comorbidities, and medications.
Primary renal disease ( = 22,136)
Hypertensive nephropathy
18.6
Diabetic kidney disease (type 2)
11.7
Diabetic kidney disease (type 1)
5.1
Chronic glomerulonephritis (except SLE)
7.4
Adult polycystic kidney disease
3.3
Chronic interstitial nephritis
2.4
SLE nephropathy
0.7
Myeloma related kidney disease
0.3
Other
28.9
Undetermined
21.7
Comorbidities ( = 21,183)
Arterial hypertension
23.3
Diabetes on insulin
6.4
Diabetes without medication
3.7
Diabetes on oral drugs
1.6
Coronary artery disease
3.4
Congestive heart failure
1.9
Other cardiac diseases
2.0
Stroke
1.2
Limb amputation
0.6
Previous kidney transplantation
1.8
Chronic obstructive pulmonary disease
0.4
Positivity for hepatitis C serology
2.7
Positivity for hepatitis B serology
1.1
Positivity for HIV positivity serology
0.5
Smoking
3.0
Malignancy
0.9
Inability to walk
1.0
Support needs for daily activities
2.3
Medications ( = 21,390)
Erythropoietin
53.9
Intravenous iron
35.1
Calcium carbonate/calcium acetate
17.8
Oral calcitriol
10.1
Intravenous calcitriol
2.9
Sevelamer hydrochloride
23.4
Oral vitamin D, nonactive form
4.9
Cinacalcet
3.7
Statins
14.4
Acetylsalicylic acid
19.3
Parenthesis content denotes the number of available responses for each item. For coronary artery disease, = 14,538; for other cardiac diseases, = 14,542.
